Patents by Inventor Nui HA

Nui HA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF ANTI-FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A5 ANTIBODIES FOR THE TREATMENT AND DIAGNOSIS OF MOOD DISORDERS
    Publication number: 20250067755
    Abstract: The present disclosure relates to a method of diagnosing a mood disorder in a subject comprising measuring serum FAM19A5 concentration with an antagonist (e.g., an antibody or antigen-binding fragment thereof) that specifically binds to FAM19A5. The present disclosure also relates to a method of treating a mood disorder in a subject in need thereof comprising administering to the subject an FAM19A5 antagonist.
    Type: Application
    Filed: July 18, 2024
    Publication date: February 27, 2025
    Applicant: Neuracle Science Co., Ltd.
    Inventors: Jae Young SEONG, Byung Joo HAM, Min-Hyeok LEE, Nui HA
  • Use of anti-family with sequence similarity 19, member A5 antibodies for the treatment and diagnosis of mood disorders
    Patent number: 12072339
    Abstract: The present disclosure relates to a method of diagnosing a mood disorder in a subject comprising measuring serum FAM19A5 concentration with an antagonist (e.g., an antibody or antigen-binding fragment thereof) that specifically binds to FAM19A5. The present disclosure also relates to a method of treating a mood disorder in a subject in need thereof comprising administering to the subject an FAM19A5 antagonist.
    Type: Grant
    Filed: October 2, 2018
    Date of Patent: August 27, 2024
    Assignee: Neuracle Science Co., Ltd.
    Inventors: Jae Young Seong, Byung Joo Ham, Min-Hyeok Lee, Nui Ha
  • INHIBITORS AND USES THEREOF
    Publication number: 20240238445
    Abstract: The present disclosure provides mimic molecules that are capable of specifically targeting a FAM19A5 protein, and thereby, inhibiting, reducing, and/or dissociating the interaction between members of the LRRC4 protein family and the FAM19A5 protein. The present disclosure also provides methods for promoting neurite outgrowth, by administering a mimic molecule described herein.
    Type: Application
    Filed: July 8, 2022
    Publication date: July 18, 2024
    Applicant: NEURACLE SCIENCE CO., LTD.
    Inventors: Jae Young SEONG, Youngjoo BYUN, Hoyun KWAK, Sitaek OH, Min-Hyeok LEE, Yongwoo JEONG, Nui HA, Eun-Ho CHO, Suhyun LEE, Sang-Myeong LEE, Yerim LEE, Eun Bee CHO, Jae Keun LEE, Han-Byul KIM, Soon-gu KWON
  • USE OF ANTI-FAM19A1 ANTAGONISTS FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES
    Publication number: 20230104540
    Abstract: The present disclosure relates to a method of treating a disease or disorder associated with an abnormality in CNS function. Also provided is a method for diagnosing and/or identifying a subject having an abnormality in CNS function. FAM19A1 antagonists that can be used with the present disclosures are also provided.
    Type: Application
    Filed: March 2, 2021
    Publication date: April 6, 2023
    Applicant: NEURACLE SCIENCE CO., LTD.
    Inventors: Bongcheol KIM, Dong Sik KIM, Soon-gu KWON, Nui HA, Jae Young SEONG, Jong Ik HWANG, Hyo Jung YONG, Eun Bee CHO
  • USE OF ANTI-FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A5 ANTIBODIES FOR THE TREATMENT AND DIAGNOSIS OF MOOD DISORDERS
    Publication number: 20200300870
    Abstract: The present disclosure relates to a method of diagnosing a mood disorder in a subject comprising measuring serum FAM19A5 concentration with an antagonist (e.g., an antibody or antigen-binding fragment thereof) that specifically binds to FAM19A5. The present disclosure also relates to a method of treating a mood disorder in a subject in need thereof comprising administering to the subject an FAM19A5 antagonist.
    Type: Application
    Filed: October 2, 2018
    Publication date: September 24, 2020
    Applicants: Neuracle Science Co., Ltd., Korea University Research and Business Foundation
    Inventors: Jae Young SEONG, Byung Joo HAM, Min-Hyeok LEE, Nui HA